RIGVIR SE - Biologically Active Food Supplement

$ 3,000.00 MXN
$ 3,000.00 MXN
Sale Sold out
Shipping calculated at checkout.
View full details

Get to know RIGVIR SE

  • Functioning

    Immunomodulatory effect that induces the body's immune defenses; and oncolytic, which affects cancer cells. The initial immune effect can be detected 2 to 6 days after taking Rigvir SE by a complete blood count test. The immunological effect is mainly manifested by an increase in the count of leukocytes, neutrophils and lymphocytes.

  • Effect after use

    Over a longer period of time, it is possible to detect a positive effect of the ECHO-7 virus on CD4+ and CD8+ T cells, B lymphocytes and natural killer (NK) cells. The direct oncolytic effect on cancer cells of the ECHO-7 virus lasts approximately 7 days; The indirect effect can last up to a month.

  • The first anticancer virus

    Rigvir SE is a food supplement with a unique formula containing a live ECHO-7 virus.Non-pathogenicNon-genetically modifiedMedical history of testingPractical use in the form of an anti-cancer drug.

  • Responsible production

    The production of Rigvir SE is a biotechnologically complicated but environmentally friendly process, with no waste or harmful emissions. Rigvir SE is manufactured in the European Union in GMP facilities according to best pharmaceutical practices.
See Scientific Articles

Rigvir México

Your safety is our priority.

Rigvir SE has completed the necessary testing, including safety, toxicology and sterility. The ingredients have been tested separately for many years.

The ECHO-7 virus is specially adapted for the recognition of various cancer cells. It is not pathogenic or genetically modified; Its safety has been demonstrated in long-term clinical practice and in preclinical trials even with a dose several times higher compared to that of Rigvir SE, which guarantees an excellent safety and tolerance profile.

Third party tested quality

The quality of Rigvir is checked at several levels:

  • During production.
  • While on the market.
  • During storage in partner warehouses to ensure required storage and monitoring conditions.
  • Independent laboratories periodically conducting random selection of Rigvir SE samples for sterility and stability testing.

Environmental responsibility

Responsible Production

The production of Rigvir SE is a biotechnologically complicated but environmentally friendly process, with no waste or harmful emissions. Rigvir SE is manufactured in the European Union in GMP facilities according to best pharmaceutical practices.